Genius Ai Detection
Payments companies reported to CMS as associated with Genius Ai Detection. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Genius Ai Detection, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Genius Ai Detection
These are the largest totals companies reported as associated with Genius Ai Detection. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Schmelzel | Stanford, CA | Diagnostic Radiology | $138,268.33 |
| Debra Ikeda | Stanford, CA | Diagnostic Radiology | $117,593.22 |
| Emily Fox Conant | Philadelphia, PA | Diagnostic Radiology | $21,100.00 |
| Terri Gizienski | Pittsburgh, PA | Diagnostic Radiology | $18,038.45 |
| Lars Grimm | Durham, NC | Diagnostic Radiology | $16,123.75 |
| Matthew Hanna | Pittsburgh, PA | Anatomic Pathology & Clinical Pathology | $11,424.96 |
| Joel Brink | Omaha, NE | Diagnostic Radiology | $8,767.11 |
| Manisha Bahl | Boston, MA | Diagnostic Radiology | $8,558.95 |
| Susan Boolbol | Poughkeepsie, NY | Surgery | $7,750.00 |
| Anthony Lucci | Houston, TX | Surgical Oncology | $7,227.23 |
Prescribed Genius Ai Detection?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.